Immunological Relationship Between Plasminogen Activator Inhibitors from Different Sources

Summary

Polyclonal antibodies have been raised against the inhibitor moiety in the purified complex between tissue plasminogen activator and its fast inhibitor (PA-inhibitor) in human plasma/ serum. A radioimmunoassay for quantitation of PA-inhibitor antigen was developed. The polyclonal antiserum and a previously described monoclonal antibody against the PA-inhibitor (14) have been used to study the immunological relationship between PA-inhibitors from plasma, serum, platelets, placenta extract and conditioned media from Hep G2 and HT 1080 cells. It was demonstrated that the ratio between PA-inhibitor activity and antigen varied considerably between the different sources. In the plasma samples studied, similar activity and antigen concentrations were found, suggesting that the PA-inhibitor in these samples mainly was in an active form. On the other hand the other sources seemed to contain variable amounts of inactive PA-inhibitor forms. Immunoadsorption experiments revealed that the PA-inhibitor (activity and antigen) from all the sources were specifically bound to the insolubilized antibodies (polyclonal and monoclonal). In no case, however, could active PA-inhibitor be eluted from the immunoadsorption columns. Also the competitive radioimmunoassays suggested that the PA-inhibitors from the different sources studied, were closely immunologically related.

Keywords

Plasminogen activator inhibitors - Immunoadsorption - Radioimmunoassay - Blood - Cell cultures

• References

• 1 Chmielewska J, Rånby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Tromb Res 1983; 31: 427-436
• 2 Kruithof EK O, Tran-Thang C, Ransijn A, Bachmann F. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984; 64: 907-913
• 3 Verheijen JH, Chang G TG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395
• 4 Thorsen S, Philips M. Isolation of tissue-type plasminogen activator - inhibitor complexes from human plasma. Biochim Biophys Acta 1984; 802: 111-118
• 5 Wiman B, Ljungberg B, Chmielewska J, Urden G, Blombäck M, Johnsson H. The role of the fibrinolytic system in deep vein thrombosis. J Lab Clin Med 1985; 105: 265-270
• 6 Hamsten A, Wiman B, DeFaire U, Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557-1563
• 7 Erickson LA, Ginsberg MH, Loskutoff DJ. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest 1984; 74: 1465-1472
• 8 Loskutoff DJ, van Mourik JA, Erickson LA, Lawrence D. Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proc Natl Acad Sci 1983; 80: 2956-2960
• 9 Emeis JJ, van Hinsbergh V WM, Verheijen JH, Wijngaards G. Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells. Biochem Biophys Res Commun 1983; 110: 392-398
• 10 Laug WE. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells. Thromb Haemostas 1985; 53: 165-169
• 11 Sprengers ED, Princen H MG, Kooistra T, van Hinsbergh V WM. Inhibition of plasminogen activator by conditioned medium of human hepatocytes and hepatoma cell line Hep G2. J Lab Clin Med 1985; 105: 751-758
• 12 Nielsen LS, Andreasen PA, Grøndahl-Hansen J, Skriver L, Danø K. Plasminogen activators catalyse conversion of inhibitor from fibrosarcoma cells to an inactive form with a lower apparent molecular mass. FEBS lett 1986; 196: 269-273
• 13 Åstedt B, Bladh B, Christenssen U, Lecander I. Different inhibition of one and two chain tissue plasminogen activator by a placental inhibitor studied with two tripeptide-p-nitroanilide substrates. Scand J Lab Clin Invest 1984; 45: 429-435
• 14 Urdén G, Johansson U, Chmielewska J, Brandt J, Wiman B. Monoclonal antibodies towards the fast inhibitor of tissue plasminogen activator from human plasma and serum. Thromb Haemostas 1986; 55: 383-387
• 15 Chmielewska J, Wiman B. Determination of tissue plasminogen activator and its “fast” inhibitor in plasma. Clin Chem 1986; 32: 482-485
• 16 Wiman B, Chmielewska J, Riinby M. Inactivation of tissue plasminogen activator in plasma: demonstration of a complex with a new rapid inhibitor. J Biol Chem 1984; 259: 3644-3647
• 17 Wiman B, Chmielewska J. A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significance. Scand J Clin Lab Invest 1985; 45 suppl (177) 43-47
• 18 Wiman B, Jacobsson L, Andersson M, Mellbring G. Determination of plasmin-α₂-antiplasmin complex in plasma samples by means of a radioimmunoassay. Scand J Clin Lab Invest 1983; 43: 27-33
• 19 Urden G, Blombiick M. Determination of tissue plasminogen activator in plasma samples by means of a radioimmunoassay. Scand J Clin Lab Invest 1984; 44: 495-502
• 20 Chmielewska J, Carlsson T, Urden G, Wiman B. On the relationship between different molecular forms of the fast inhibitor of tissue plasminogen activator. Fibrinolysis 1987; In press
• 21 Hekman CM, Loskutoff DJ. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. J Biol Chem 1985; 260: 11581-11587
• 22 Erickson LA, Hekman CM, Loskutoff DJ. The primary plasminogen - activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related. Proc Natl Acad Sci 1985; 82: 8710-8714
• 23 Loskutoff DJ, Roegner K, Erickson LA, Schleef RR, Huttenlocher A, Coleman PL, Gelehrter TD. The dexamethasone-induced inhibitor of plasminogen activator in hepatoma cells is antigenicallyrelated to an inhibitor produced by bovine aortic endothelial cells. Thromb Haemostas 1986; 55: 8-11
• 24 Lecander I, Åstedt B. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. Brit J Haematol 1986; 62: 221-228
• 25 Loskutoff DJ, Roegner K, Erickson LA, Schleef RR, Huttenlocher A, Coleman PL, Gelehrter TD. The dexamethasone-induced inhibitor of plasminogen activator in hepatoma cells is antigenicallyrelated to an inhibitor produced by bovine aortic endothelial cells. Thromb Haemostas 1986; 55: 8-11
• 26 Philips M, Juul A-G, Thorsen S, Selmer J, Zeuthen J. Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta. Thromb Haemostas 1986; 55: 213-217